Delivery Order SPE2DB22D3016-SPE2DB24FAJY4

Award Date 1/22/24
Potential Completion Date 2/12/24
Potential Value $254K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency Troop Support Medical awarded a $2,535.55 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide YF-VAX 1 DOSE VIALS. This contract has a completion date of February 23, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this delivery order, which is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the supply of YF-VAX 1 dose vials, with a potential value of $25,355.50 and a completion date of March 27, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp is an experienced federal contractor, holding an indefinite delivery...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The $25,355.50 contract is for the delivery of YF-VAX 1 dose vials, with a completion date of February 26, 2024. Amerisourcebergen Drug Corp has received numerous similar awards from DLA to supply pharmaceuticals, medical supplies, and related distribution services in support of military treatment...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the supply of YF-VAX 1 dose vials, with a potential value of $1,521.33 and a completion date of March 21, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this order, which is not designated as a set-aside contract. The company also...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of YF-VAX 1 dose vials, with a potential value of $8,620.87 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation mentioned. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The order is for 1 dose vials of the YF-VAX vaccine, with a completion date of February 28, 2024 and a potential value of $1,014.22. This order is not under a set-aside program. Amerisourcebergen Drug Corporation is a subsidiary of the Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of YF-VAX 1 DOSE VIALS, a pharmaceutical product, with a potential value of $3,042.66 and a completion date of March 21, 2024. Amerisourcebergen Drug Corp has received numerous federal contract awards from DLA Troop...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is to provide YF-VAX 1 dose vials, with a completion date of February 23, 2024 and a potential value of $15,213.30. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation indicated. This order is placed under an Indefinite Delivery Contract (IDC) awarded solely to Amerisourcebergen Drug Corp...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award, with a ceiling value of $2,535.55, is for the supply of YF-VAX 1 dose vials, a pharmaceutical product. The delivery order has an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corp is the prime contractor and this award is part of a larger $999,999,999.00 indefinite delivery...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,028.44 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of YF-VAX 1 dose vials. The contract has a completion date of February 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on this contract and does not have any major subcontractors. This delivery order contract is part of a larger indefinite delivery contract (IDC) that Amerisourcebergen...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FAJY4
    Delivery Order

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide YF-VAX 1 dose vials. The $253,555.00 contract has a completion date of February 12, 2024. Amerisourcebergen Drug Corp, a for-profit organization, has a history of providing pharmaceuticals, medical supplies, and distribution services to support DLA Troop Support Medical programs. This order does not have a set-aside designation. Amerisourcebergen Drug Corp's parent company is Cencora, Inc., which does business as Amerisourcebergen.

Generated 4/22/24, 9:35 AM